Item 16. Form 10-K Summary

Form 10-K Summary

None.

Index to Financial Statements

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange

Act of 1934, the Registrant has duly

caused this report to be signed on its behalf by the undersigned,

thereunto duly authorized.

Henry Schein, Inc.

By: /s/ STANLEY M. BERGMAN

Stanley M. Bergman

Chairman and Chief Executive Officer

February 24, 2026

Pursuant to the requirements of the Securities Exchange Act of 1934, this

report has been signed below by the

following persons on behalf of the Registrant and in the capacities and on

the dates indicated.

Signature

Capacity

Date

/s/ STANLEY M. BERGMAN

Chairman, Chief Executive Officer

February 24, 2026

Stanley M. Bergman

and Director (principal executive officer)

/s/ RONALD N. SOUTH

Senior Vice President, Chief

Financial Officer

February 24, 2026

Ronald N. South

(principal financial and accounting officer)

/s/ MOHAMAD ALI

Director

February 24, 2026

Mohamad Ali

/s/ WILLIAM K. DANIEL

Director

February 24, 2026

William K. Daniel

/s/ DEBORAH DERBY

Director

February 24, 2026

Deborah Derby

/s/ CAROLE T. FAIG

Director

February 24, 2026

Carole T. Faig

/s/ JOSEPH L. HERRING

Director

February 24, 2026

Joseph L. Herring

/s/ ROBERT J. HOMBACH

Director

February 24, 2026

Robert J. Hombach

/s/ KURT P.

KUEHN

Director

February 24, 2026

Kurt P.

Kuehn

/s/ PHILIP A. LASKAWY

Director

February 24, 2026

Philip A. Laskawy

/s/ MAX LIN

Director

February 24, 2026

Max Lin

/s/ ANNE H. MARGULIES

Director

February 24, 2026

Anne H. Margulies

/s/ SCOTT SEROTA

Director

February 24, 2026

Scott Serota

/s/ BRADLEY T. SHEARES,

PH.D.

Director

February 24, 2026

Bradley T. Sheares,

Ph.D.

/s/ REED V.

TUCKSON, M.D., FACP

Director

February 24, 2026

Reed V.

Tuckson, M.D., FACP